ProfileGDS4718 / 205103_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 69% 69% 66% 69% 70% 69% 70% 72% 73% 71% 69% 69% 69% 67% 66% 69% 67% 69% 67% 74% 74% 70% 66% 66% 70% 68% 69% 68% 66% 73% 68% 67% 71% 69% 67% 65% 70% 70% 72% 71% 71% 68% 68% 71% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.8033169
GSM549102patient 115, normal, homogenized [OPG study]6.7904869
GSM549104patient 119, normal, homogenized [OPG study]6.5911766
GSM549108patient 138, normal, homogenized [OPG study]6.752469
GSM549119patient 077, normal, homogenized [OPG study]6.8234870
GSM549133patient 032, cancer, homogenized [OPG study]6.8082369
GSM549139patient 042, cancer, homogenized [OPG study]6.9015770
GSM549099patient 107, normal, homogenized [OPG study]7.0021572
GSM549109patient 139, normal, homogenized [OPG study]7.1407973
GSM549110patient 046, normal, homogenized [OPG study]6.9074771
GSM549114patient 063, normal, homogenized [OPG study]6.7662769
GSM549122patient 082, normal, homogenized [OPG study]6.8341569
GSM549134patient 033, cancer, homogenized [OPG study]6.7713969
GSM549136patient 036, cancer, homogenized [OPG study]6.667867
GSM549140patient 044, cancer, homogenized [OPG study]6.5256666
GSM549111patient 047, normal, homogenized [OPG study]6.7810669
GSM549113patient 057, normal, homogenized [OPG study]6.60767
GSM549132patient 031, cancer, homogenized [OPG study]6.8347369
GSM549137patient 038, cancer, homogenized [OPG study]6.6219467
GSM549142patient 047, cancer, homogenized [OPG study]7.1639774
GSM549100patient 110, normal, homogenized [OPG study]7.1546674
GSM549107patient 135, normal, homogenized [OPG study]6.9138370
GSM549115patient 068, normal, homogenized [OPG study]6.5558666
GSM549116patient 072, normal, homogenized [OPG study]6.5543566
GSM549120patient 078, normal, homogenized [OPG study]6.8774670
GSM549131patient 030, cancer, homogenized [OPG study]6.7564568
GSM549118patient 074, normal, homogenized [OPG study]6.8162369
GSM549129patient 027, cancer, homogenized [OPG study]6.7337668
GSM549123patient 088, normal, homogenized [OPG study]6.5290566
GSM549124patient 006, cancer, homogenized [OPG study]7.0802673
GSM549126patient 015, cancer, homogenized [OPG study]6.7280668
GSM549128patient 025, cancer, homogenized [OPG study]6.7069867
GSM549103patient 117, normal, homogenized [OPG study]6.8587671
GSM549117patient 073, normal, homogenized [OPG study]6.7047569
GSM549138patient 041, cancer, homogenized [OPG study]6.6811167
GSM549141patient 045, cancer, homogenized [OPG study]6.5060565
GSM549130patient 028, cancer, homogenized [OPG study]6.8828870
GSM549101patient 111, normal, homogenized [OPG study]6.8874270
GSM549105patient 128, normal, homogenized [OPG study]7.0536172
GSM549106patient 134, normal, homogenized [OPG study]7.0396971
GSM549112patient 048, normal, homogenized [OPG study]6.9495671
GSM549125patient 011, cancer, homogenized [OPG study]6.7277868
GSM549127patient 024, cancer, homogenized [OPG study]6.7990568
GSM549135patient 035, cancer, homogenized [OPG study]7.0022671